{
    "relation": [
        [
            "Feature key",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti"
        ],
        [
            "Position(s)",
            "44 \u2013 44",
            "46 \u2013 46",
            "97 \u2013 97",
            "401 \u2013 401"
        ],
        [
            "Length",
            "1",
            "1",
            "1",
            "1"
        ],
        [
            "Description",
            "T \u2192 A in FASPS2; strongly reduces kinase activity. 2 Publications Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.42 \"Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome.\" Xu Y., Padiath Q.S., Shapiro R.E., Jones C.R., Wu S.C., Saigoh N., Saigoh K., Ptacek L.J., Fu Y.H. Nature 434:640-644(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT FASPS2 ALA-44. Ref.45 \"Casein kinase idelta mutations in familial migraine and advanced phase.\" Brennan K.C., Bates E.A., Shapiro R.E., Zyuzin J., Hallows W.C., Huang Y., Lee H.Y., Jones C.R., Fu Y.H., Charles A.C., Ptacek L.J. Sci. Transl. Med. 5:183ra56-183ra56(2013) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS FASPS2 ALA-44 AND ARG-46, CHARACTERIZATION OF VARIANTS FASPS2 ALA-44 AND ARG-46, FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES.",
            "H \u2192 R in FASPS2; strongly reduces kinase activity. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.45 \"Casein kinase idelta mutations in familial migraine and advanced phase.\" Brennan K.C., Bates E.A., Shapiro R.E., Zyuzin J., Hallows W.C., Huang Y., Lee H.Y., Jones C.R., Fu Y.H., Charles A.C., Ptacek L.J. Sci. Transl. Med. 5:183ra56-183ra56(2013) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS FASPS2 ALA-44 AND ARG-46, CHARACTERIZATION OF VARIANTS FASPS2 ALA-44 AND ARG-46, FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES.",
            "S \u2192 C in breast cancer samples; infiltrating ductal carcinoma; somatic mutation. 2 Publications Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.43 \"The consensus coding sequences of human breast and colorectal cancers.\" Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V. , Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W., Velculescu V.E. Science 314:268-274(2006) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT [LARGE SCALE ANALYSIS] CYS-97. Ref.44 \"Patterns of somatic mutation in human cancer genomes.\" Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G. , Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R. Nature 446:153-158(2007) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS [LARGE SCALE ANALYSIS] CYS-97 AND ALA-401.",
            "P \u2192 A.1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.44 \"Patterns of somatic mutation in human cancer genomes.\" Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G. , Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R. Nature 446:153-158(2007) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS [LARGE SCALE ANALYSIS] CYS-97 AND ALA-401. Corresponds to variant rs56124628 [ dbSNP | Ensembl ]."
        ],
        [
            "Graphical view",
            "",
            "",
            "",
            ""
        ],
        [
            "Feature identifier",
            "VAR_029075",
            "VAR_069801",
            "VAR_036451",
            "VAR_042081"
        ],
        [
            "Actions",
            "",
            "",
            "",
            ""
        ]
    ],
    "pageTitle": "CSNK1D - Casein kinase I isoform delta - Homo sapiens (Human)",
    "title": "",
    "url": "http://www.uniprot.org/uniprot/P48730",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 25,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042985140.15/warc/CC-MAIN-20150728002305-00155-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 812540907,
    "recordOffset": 812466652,
    "tableOrientation": "HORIZONTAL",
    "lastModified": "Wed, 22 Jul 2015 00:00:00 GMT",
    "textBeforeTable": "Natural variant A \u2192 D in AAC50807 (PubMed:8786104).Curated 1 330\u00a0\u2013\u00a0330 <p>Reports difference(s) between the canonical sequence (displayed by default in the entry) and the different sequence submissions merged in the entry. These various submissions may originate from different sequencing projects, different types of experiments, or different biological samples. Sequence conflicts are usually of unknown origin.</p><p><a href='../manual/conflict' target='_top'>More...</a></p>Sequence conflicti Actions Feature identifier Graphical view Description Length Position(s) Feature key Experimental InfoBLASTProtParamProtScaleCompute pI/MWPeptideMassPeptideCutterGO <p>The checksum is a form of redundancy check that is calculated from the sequence. It is useful for tracking sequence updates.</p> <p>It should be noted that while, in theory, two different sequences could have the same checksum value, the likelihood that this would happen is extremely low.</p> <p>However UniProtKB may contain entries with identical sequences in case of multiple genes (paralogs).</p> <p>The checksum is computed as the sequence 64-bit Cyclic Redundancy Check value (CRC64) using the generator polynomial: x<sup>64</sup> + x<sup>4</sup> + x<sup>3</sup> + x + 1. The algorithm",
    "textAfterTable": "Alternative sequence Feature key Position(s) Length Description Graphical view Feature identifier Actions <p>Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.</p><p><a href='../manual/var_seq' target='_top'>More...</a></p>Alternative sequencei 400\u00a0\u2013\u00a0415 16 IPGRV\u2026SVVHR \u2192 NSIPFEHHGK in isoform 2. 2 Publications <p>Manually curated information that is based on statements in scientific articles for which there is no experimental support.</p> <p><a href=\"/manual/evidences#ECO:0000303\">More\u2026</a></p> Manual assertion based on opinion ini Ref.4 \"Complete sequencing and characterization of 21,243 full-length human cDNAs.\" Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.",
    "hasKeyColumn": false,
    "keyColumnIndex": -1,
    "headerRowIndex": 0
}